Adage Capital Partners Gp, L.L.C. Revolution Medicines, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $51.6 Billion
- Q1 2025
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 394,000 shares of RVMD stock, worth $15.1 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
394,000
Previous 650,000
39.38%
Holding current value
$15.1 Million
Previous $28.4 Million
51.0%
% of portfolio
0.03%
Previous 0.05%
Shares
8 transactions
Others Institutions Holding RVMD
# of Institutions
307Shares Held
189MCall Options Held
186KPut Options Held
672K-
Vanguard Group Inc Valley Forge, PA16.6MShares$636 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA13.5MShares$518 Million2.75% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$513 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA11.8MShares$451 Million0.08% of portfolio
-
Janus Henderson Group PLC London, X010.2MShares$390 Million0.21% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.36B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...